ArticleScientific reports2018

Development and characterisation of a panel of phosphatidylinositide 3-kinase - mammalian target of rapamycin inhibitor resistant lung cancer cell lines.

Susan Heavey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.